骨质疏松症的药物治疗进展

被引：13

作者：

张晗祥

骆旭东

机构：

[1] 遵义医学院第三附属医院骨科

来源：

中国骨质疏松杂志 | 2009年 / 15卷 / 10期

关键词：

骨质疏松; 药物治疗; 骨形成; 骨吸收; 骨矿化;

D O I：

暂无

中图分类号：

R580 [];

学科分类号：

摘要：

药物治疗是治疗骨质疏松症的重要手段之一,目前药物治疗可分为三类:抗骨重吸收、促骨形成和骨矿化药物,每类药物治疗都各有其优缺点,笔者就几类常见骨质疏松治疗药物近年的研究进展作一概述。

引用

页码：784 / 788

页数：5

共 10 条

[1]

仙灵骨葆治疗原发性骨质疏松症的临床研究 [J].

宋玲 ;

李刚 .

中国中医骨伤科杂志, 2009, 17 (03) :40-41

[2]

Decreased bone turnover despite persistent secondary hyperparathyroidism during prolonged treatment with imatinib.[J].S. O' Sullivan;A. Horne;D. Wattie;F. Porteous;K. Callon;G. Gamble;P. Ebeling;P. Browett;A. Grey.Bone.2009,

[3]

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial [J].

Miller, Paul D. ;

Bolognese, Michael A. ;

Lewiecki, E. Michael ;

McClung, Michael R. ;

Ding, Beiying ;

Austin, Matthew ;

Liu, Yu ;

Martin, Javier San .

BONE, 2008, 43 (02) :222-229

[4]

Advances in bone biology and new treatments for bone loss [J].

Gallagher, J. Chris .

MATURITAS, 2008, 60 (01) :65-69

[5]

The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin:: Clinical implications [J].

Vega, Damaris ;

Maalouf, Naim M. ;

Sakhaee, Khashayar .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (12) :4514-4521

[6]

Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials [J].

Winzenberg, Tania ;

Shaw, Kelly ;

Fryer, Jayne ;

Jones, Graeme .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 333 (7572) :775-778F

[7]

Imatinib mesylate (Gleevec?) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.[J].Iman El Hajj Dib;Marlène Gallet;Romuald Mentaverri;Nicolas Sévenet;Michel Brazier;Said Kamel.European Journal of Pharmacology.2006, 1

[8]

Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies [J].